Market Overview

The artificial intelligence in genomics market is experiencing significant growth as AI-driven technologies revolutionize genomic research, precision medicine, and bioinformatics. AI plays a crucial role in genome sequencing, variant analysis, and predictive modeling, accelerating discoveries in genetic disorders, personalized medicine, and drug development. The demand for AI in genomics is being driven by the increasing volume of genomic data, advancements in machine learning algorithms, and the growing adoption of cloud-based genomic data analysis solutions.

Market Size and Share

The Global Artificial Intelligence In Genomics Market Size was estimated at 4.23 (USD Billion) in 2024. The Artificial Intelligence In Genomics Market Industry is expected to grow from 5.65 (USD Billion) in 2025 to 75.86 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 33.46% during the forecast period (2025 - 2034). North America holds the largest share due to strong government funding for genomic research, high adoption of AI in healthcare, and the presence of leading biotech firms. The Asia-Pacific region is expected to exhibit rapid growth, driven by increasing investments in genomic studies, AI startups, and healthcare infrastructure modernization.

Market Drivers

• Growing Adoption of AI for Genome Sequencing: AI-powered solutions enhance next-generation sequencing (NGS) accuracy and efficiency, reducing the time and cost of genomic data processing.
• Rise in Personalized Medicine and Precision Oncology: AI is revolutionizing genomic diagnostics by identifying disease markers for targeted therapies in cancer and rare genetic disorders.
• Advancements in Machine Learning and Deep Learning: AI-driven pattern recognition in genomics facilitates disease risk prediction, gene editing, and biomarker discovery.
• Expanding Applications in Drug Discovery: AI accelerates drug development by analyzing gene expression patterns, protein interactions, and CRISPR-based gene editing data.

Challenges and Restraints

• High Costs of AI Integration in Genomics
• Concerns Over Genomic Data Privacy and Ethical Issues
• Limited Availability of AI-Ready Genomic Datasets

Market Trends

• Expansion of AI-Based Genomic Data Interpretation Platforms
• Increasing Collaboration Between AI Startups and Genomic Research Firms
• Adoption of Cloud-Based Genomics AI Solutions
• Integration of AI in Gene Therapy and CRISPR Research

Segmental Analysis

• By Technology:
• Machine Learning
• Deep Learning
• Natural Language Processing (NLP)
• By Application:
• Genome Sequencing
• Gene Expression Analysis
• Genetic Disease Prediction
• Drug Discovery & Development
• By End-User:
• Pharmaceutical & Biotech Companies
• Academic & Research Institutes
• Healthcare Providers

Key Market Players

·         Oxford Nanopore Technologies

·         Qiagen

·         Adaptive Biotechnologies

·         Invitae

·         NeoGenomics

·         Agilent

For more information, please visit us at marketresearchfuture.